Physician profile
Ran Kim
NPI 1437237005
$23,816.60
in general payments reported to CMS, 2019-2025
49 companies · $1,651 in 2025
The $1,651 reported for 2025 was more than what 79% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $987 · 2021: $1,983 · 2022: $4,623 · 2023: $1,223 · 2024: $1,130 · 2025: $1,651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,012 · Travel and Lodging: $993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,011.51 |
| Travel and Lodging | $993.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,548.62 | 2019-2025 | Da Vinci Surgical System |
| Kerecis Limited | $2,576.23 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Medtronic USA, INC. | $2,394.71 | 2019-2020 | |
| Davol INC. | $1,994.44 | 2019-2023 | Phasix Mesh |
| Medtronic, INC. | $1,972.60 | 2021-2023 | Venaseal, Interstim |
| Acell, INC. | $1,956.19 | 2019-2020 | |
| Axonics, INC. | $1,265.47 | 2020-2023 | Axonics |
| Medical Device Business Services, INC. | $1,225.10 | 2019 | |
| W. L. Gore & Associates, INC. | $1,087.31 | 2019 | |
| Heron Therapeutics, INC. | $443.15 | 2021-2025 | Zynrelef, Aponvie |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $394.39 | 2021-2025 | Xifaxan, Trulance, Relistor |
| Ethicon US, LLC | $338.65 | 2019-2024 | Echelon Circular, Echelon Flex, Harmonic |
| Covidien Lp | $325.33 | 2019 | |
| Integra Lifesciences Corporation | $265.97 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Novo Nordisk INC | $231.86 | 2023 | Wegovy |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prescient Surgical | $195.68 | 2019 | |
| Galderma Laboratories, L.P. | $171.53 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $158.38 | 2019 | |
| Coloplast Corp | $157.40 | 2023-2024 | Sensura Mio |
| Smith+Nephew, INC. | $149.98 | 2025 | Collagenase Santyl |
| Tela Bio, INC. | $148.60 | 2020 | |
| Trevena, INC. | $142.73 | 2022 | |
| Abbvie INC. | $138.84 | 2020-2025 | |
| Nevro Corp. | $126.63 | 2019 | |
| Allergan, INC. | $118.89 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $108.73 | 2019-2025 | Entyvio |
| Ferring Pharmaceuticals INC. | $102.41 | 2019-2021 | |
| Surgenex LLC | $95.91 | 2025 | Pellograft, Ardeograft, Surgraft |
| Braintree Laboratories, INC. | $93.94 | 2021-2025 | Sutab, Suflave |
| Medela LLC | $90.83 | 2020 | |
| Nestle Healthcare Nutrition INC. | $88.59 | 2021-2022 | |
| Polarityte, INC. | $78.97 | 2021 | |
| Hollister Incorporated | $75.35 | 2019-2020 | |
| Alfasigma USA, INC. | $57.76 | 2020 | |
| Sanara Medtech INC. | $51.02 | 2022-2024 | Celleraterx |
| Acera Surgical, INC. | $48.34 | 2024-2025 | Restrata Wound Matrix |
| Olympus America INC. | $45.92 | 2019 | |
| Revance Therapeutics, INC. | $42.84 | 2025 | Daxi |
| Hologic Sales and Service, LLC | $38.41 | 2023 | Biozorb, Trident Specimen Radiography System |
| Janssen Biotech, INC. | $38.21 | 2025 | Tremfya |
| Portola Pharmaceuticals, LLC | $35.45 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $33.66 | 2025 | |
| Merck Sharp & Dohme LLC | $29.15 | 2019-2020 | |
| La Jolla Pharmaceutical Company | $26.82 | 2023 | Xerava |
| Lsi Solutions INC | $25.46 | 2024 | Ti-Knot, Running Device |
| Shire North American Group INC | $22.31 | 2019 | |
| Polynovo North America LLC | $20.24 | 2022 | |
| Coopersurgical, INC. | $19.67 | 2021 | |
| Teleflex LLC | $17.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ran Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.